Previous Page  19 / 26 Next Page
Information
Show Menu
Previous Page 19 / 26 Next Page
Page Background

Page 57

Volume 3

August 5-6, 2019 | Singapore

CANCER RESEARCH AND PHARMACOLOGY

STRUCTURAL BIOCHEMISTRY, STEM CELLS AND MOLECULAR BIOLOGY

24

th

International Conference on

International Congress on

&

Cancer Research 2019 & Structural Biochemistry 2019

August 5-6, 2019

Journal of Cancer and Metastasis Research

Clin Psychol Cog Sci, Volume 3

Oncofertility: Effect of chemotherapeutics and gamma tocopherol (gT) on breast cancer

and primary-derived ovarian cells

Fiona Young

Flinders University, Australia

Statement of the Problem

: Premenopausal breast-

cancer patients are treated with a combination

of chemotherapeutics, commonly doxorubicin

(adriamycin) and cyclophosphamide (‘AC’), but

the combined toxicity of ‘AC’

in vitro

has not been

reported. Additionally, ‘AC’-treated breast cancer

survivors suffer premature ovarian failure and adverse

effects caused by estrogen (E2) depletion. Each

chemotherapeutic generates reactive oxygen species

(ROS). Gamma- tocopherol (gT), a constituent of

antioxidant Vitamin E, has anticancer activity. The

aims were to examine the hypotheses that exposing

a human breast cancer cell-line (MCF7) to AC+gT

would reduce ROS, but gT would maintain anti-

cancer activity. Secondly, that AC+gT would be less

cytotoxic to primary-derived ovarian cells than ‘AC’.

Methodology & Findings

: MCF7 cells were exposed to doxorubicin (Dox), 4-hydroxyperoxy-cyclophosphamide (CYC),

Dox+CYC, gT, and Dox+CYC+gT

in vitro

. Doxorubicin, and gT, but not CYC, caused dose- dependent cytotoxicity. Dox+CYC

caused significant cytotoxicity similar to doxorubicin alone. Dox+CYC+gT caused significantly more MCF7-cell death than

Dox+CYC.

Follicles (an egg surrounded by proliferating cells) from mouse ovaries were cultured in Matrigel. Follicle diameters and E2

synthesis increased under control conditions. The percentages of viable cells per follicle after 6d in 0.3% DMSO solvent control

(for gT) were 60±9%, and 57±14% after exposure to the MCF7-derived EC25 value for gT. Exposure to the MCF7-derived EC25

values for Dox+CYC resulted in 16±5% (p<0.05, 37% of control), whereas Dox+CYC+gT (MCF7:EC25+EC25+EC25) resulted

in 44±7% viable cells per follicle (74% of control).

Conclusion & Significance

: Hypotheses were supported: gT increased Dox+CYC cytotoxicity against MCF7 cancer cells but

decreased Dox+CYC cytotoxicity towards primary-derived proliferating ovarian cells. gT anti-cancer mechanism of action

requires elucidation, but antioxidant activity may protect follicles against chemotherapeutic cytotoxicity.

Fiona.Young@Flinders.edu.au